Duruöz, Mehmet TuncayBodur, HafizeAtaman, ŞebnemGürer, GülcanAkgül, ÖzgürÇay, H. F.Çapkın, ErolAltan İnceoğlu, Lale2024-02-262024-02-262023Duruöz, M. T., Bodur, H., Ataman, Ş., Gürer, G., Akgül, Ö., Çay, H. F. ... Altan İnceoğlu, L. (2023). Cross-sectional analysis of cardiovascular disease and risk factors in patients with spondyloarthritis: A real-life evidence from biostar nationwide registry. European Congress of Rheumatology (EULAR) içinde (615-616. ss.). Milan, Italy, 31 May-03 June, 2023. https://dx.doi.org/10.1136/annrheumdis-2023-eular.18000003-49671468-2060https://dx.doi.org/10.1136/annrheumdis-2023-eular.1800https://hdl.handle.net/20.500.12511/12315Background: Association between spondyloarthritis and cardiovascular (CV) diseases is a complex issue with variable outcomes. Objectives: This study aimed to assess the prevalence rates of CV diseases and to analyze the impact of CV risk factors on CV disease in patients with spondyloarthritis. Methods: A multi-center cross-sectional study using BioSTAR (Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs Registry) database was performed on patients with spondyloarthritis. Socio-demographic, laboratory and clinical, data were collected. Patients with and without major adverse cardiovascular events (MACE) were grouped as Group 1 and Group 2.The primary outcome was the prevalence rates of CV disease and CV risk factors in the overall group. The secondary outcome was the difference in socio-demographic and clinical characteristics between the groups and predictive risk factors for CV disease.eninfo:eu-repo/semantics/openAccessSpondyloarthritisTraditional CardiovascularRheumatoid ArthritisConference Object82Supplement: 161561610.1136/annrheumdis-2023-eular.1800Q1001107398702065